Closed · CDC-RFA-GH16-16320301SUPP19 · CFDA 93.067 · Discretionary

Supporting Implementation of HIV and TB Services for Epidemic Control in the Republic of Mozambique under PEPFAR

Federal grant opportunity posted by Centers for Disease Control - CGH, cataloged on Grants.gov.

up to $1.0M
Award range
Closed
Status
July 1, 2019
Close date
1
Expected awards

The verdict

Supporting Implementation of HIV and TB Services for Epidemic Control in the Republic of Mozambique under PEPFAR is a closed discretionary listing from Centers for Disease Control - CGH that offered Up to $1,037,398 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 821 other opportunities from Centers for Disease Control - CGH.

up to $1.0M
award range
Closed
application status
1
expected award
93.067
CFDA program

Archived opportunity record

Supporting Implementation of HIV and TB Servi… is closed (last close July 1, 2019). The parent program page for CFDA 93.067 is the reliable place to catch re-announcements. Centers for Disease Control - CGH still indexes 821 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed July 1, 2019

Posted May 20 Closes Jul 1

Est. Total Funding

$1,037,398

Expected Awards

1

Instrument

Cooperative Agreement

Description

The goal and objectives of the program is to solicit comprehensive and cost-effective technical assistance, capacity building and program implementation expertise for PEPFAR and Global Fund-supported global health activities (with emphasis on but not limited to HIV/AIDS) in the five programmatic areas listed under the purpose section of this FOA. This announcement will also support Global Fund implementing partners in assessing HIV service delivery and will develop technical assistance plans and strategies. This FOA will not provide direct program implementation. Rather, it will provide technical assistance support to PEPFAR and Global Fund implementing partners engaged in program implementation and scale-up activities.This FOA will support HHS/CDC’s efforts to provide high-quality, targeted technical assistance to ensure that the PEPFAR and Global Fund-supported countries have the capacity and necessary technical expertise to assume responsibility for service delivery and adequately respond to their HIV epidemics. While this announcement will address several of the overall program goals and objectives, it will primarily focus on five critical PEPFAR-supported technical areas. Applicants are expected to respond to one or more of the following program areas:Prevention of Mother-to-Child Transmission of HIV/AIDS (PMTCT);HIV Care and Treatment Clinical Services for adults and children;HIV Pediatric Care and Treatment (PEDs);Surveillance and Strategic Information (SI); andLaboratoryMozambique is a predominantly rural country with a population of 26 million people. The 2009 National AIDS Survey (INSIDA), the latest nationally- and provincially-representative population-based survey for which representative results are available, showed the national HIV prevalence to be 11.5%; although there was substantial variation in regional HIV prevalence, ranging from 25.1% in Southern provinces to 3.7% in Northern provinces. Generally, HIV testing in Mozambique has remained low; INSIDA 2009 found that only 37% of women and 19% of men aged 15-49 had ever been tested for HIV. As per official UNAIDS estimates, in 2014, an estimated 1,655,167 people were living with HIV (PLHIV), with a higher prevalence among women (13.1% vs 9.2% in men) and especially among young women aged 15-24 years (estimated HIV prevalence is 11.1% vs 3.1% in young men). The HIV epidemic has contributed to a low life expectancy of 51 years, and there are about 848,000 orphaned children. As of 2014, approximately 54% of estimated PLHIV were in care and 40% were on antiretroviral therapy (ART). TB is a public health concern in the country, with TB case detection rates and TB/HIV co-infection rates of 37% and 56%, respectively.While epidemiological data on key populations (KP) in Mozambique is limited, integrated biological and behavioral surveillance (IBBS) 2011/2012 data indicated that the prevalence of HIV among female sex workers was 31.2% in Maputo, 23.6% in Beira, and 17.8% in Nampula.The overall goal of this NOFO is to implement interventions to support the continuum of response for HIV and TB in Mozambique. As such, awardees will be expected to implement comprehensive and evidence-based interventions to support prevention, care, support, and treatment interventions for HIV and TB in facilities and communities. This also includes, but is not limited to the following cross-cutting areas that are critical for achieving epidemic control: HRH, GBV, HSS, laboratory, surveillance and surveys, sexual prevention, health communication, health economics, performance-based financing, epidemiologic assistance, DQA, monitoring and evaluation (M&E), information systems, and impact and program evaluation.Awardees will also be expected to provide technical assistance and capacity building support to host governmental institutions and other stakeholders/partners, including GF recipients, involved in providing HIV and TB services in Mozambique.The purpose of this NOFO is to support the Government of Mozambique to achieve epidemic control through delivery of high quality HIV anThe purpose of this NOFO is to support the Government of Mozambique to achieve epidemic control through delivery of high quality HIV and TB services by implementing sustainable models of community and facility based services that cover the full continuum of response.

Catch-all / unrestricted eligibility mark · CDC-RFA-GH16-16320301SUPP19

Grants.gov marks Supporting Implementation of HIV and TB Servi… with a catch-all / unrestricted eligibility code (Others (see official listing text)). Read the official announcement text for the real applicant filter — the code alone is not a door list. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Health (HL). This eligibility-code string dominates the Centers for Disease Control - CGH book (550 peers, 67% of 822).

Code 25
Others (see official listing text)

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

OGSTIMS@cdc.gov 770-488-2700

What to do next

Supporting Implementation of HIV and TB Servi… is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.067 may publish future NOFOs under the same assistance listing. Open program
  • Global AIDS indexes 2 Grants.gov listings in this extract. Program profile
  • Centers for Disease Control - CGH lists 821 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants